Article Information
History
- June 7, 2022.
Article Versions
- Version 1 (March 7, 2022 - 21:45).
- Version 2 (June 1, 2022 - 12:07).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Michiel J.M. Niesen1,+,
- Karthik Murugadoss1,+,
- Patrick J. Lenehan1,+,
- Aron Marchler-Bauer2,
- Jiyao Wang2,
- Ryan Connor2,
- J. Rodney Brister2,
- AJ Venkatakrishnan1 and
- Venky Soundararajan1,*
- 1nference, One Main St, East Arcade, Cambridge, Massachusetts 02139, USA
- 2National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA
- ↵*Correspondence to: Venky Soundararajan (venky{at}nference.net)
Posted June 07, 2022.
Quantifying the immunological distinctiveness of emerging SARS-CoV-2 variants in the context of prior regional herd exposure
